12:00 AM
 | 
Sep 01, 2014
 |  BC Week In Review  |  Company News  |  Deals

Altacor, Esperante deal

Life science investment company Esperante acquired ophthalmology company Altacor for an undisclosed amount. Altacor markets...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >